Oramed Pharmaceuticals Inc (ORMP)
2.35
+0.01
(+0.43%)
USD |
NASDAQ |
May 03, 16:00
2.355
0.00 (0.00%)
After-Hours: 20:00
Oramed Pharmaceuticals Cash from Financing (Quarterly): -25.00M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -25.00M |
| September 30, 2023 | 74.55M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 2.43M |
| December 31, 2022 | 4.175M |
| September 30, 2022 | 4.313M |
| June 30, 2022 | -0.001M |
| March 31, 2022 | 2.292M |
| November 30, 2021 | 60.56M |
| August 31, 2021 | 55.02M |
| May 31, 2021 | 21.86M |
| February 28, 2021 | 25.43M |
| November 30, 2020 | 0.586M |
| August 31, 2020 | 1.478M |
| May 31, 2020 | 19.98M |
| February 29, 2020 | 2.316M |
| November 30, 2019 | 0.013M |
| August 31, 2019 | 0.00 |
| May 31, 2019 | 0.00 |
| February 28, 2019 | 0.00 |
| November 30, 2018 | 0.00 |
| August 31, 2018 | 16.49M |
| May 31, 2018 | 0.283M |
| February 28, 2018 | 0.718M |
| November 30, 2017 | 5.16M |
| Date | Value |
|---|---|
| August 31, 2017 | 1.266M |
| May 31, 2017 | 0.00 |
| February 28, 2017 | 0.00 |
| November 30, 2016 | 0.32M |
| August 31, 2016 | 0.111M |
| May 31, 2016 | 0.052M |
| February 29, 2016 | 11.72M |
| November 30, 2015 | 0.164M |
| August 31, 2015 | 4.88M |
| May 31, 2015 | 0.00 |
| February 28, 2015 | 0.008M |
| November 30, 2014 | 4.833M |
| August 31, 2014 | 0.002M |
| May 31, 2014 | 0.143M |
| February 28, 2014 | 16.50M |
| November 30, 2013 | 0.00 |
| August 31, 2013 | 4.373M |
| May 31, 2013 | 0.00 |
| February 28, 2013 | -0.0075M |
| November 30, 2012 | 1.458M |
| August 31, 2012 | 3.489M |
| May 31, 2012 | 0.00 |
| February 29, 2012 | 0.00 |
| November 30, 2011 | 0.00 |
| August 31, 2011 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-25.00M
Minimum
Dec 2023
74.55M
Maximum
Sep 2023
13.16M
Average
2.316M
Median
Feb 2020
Cash from Financing (Quarterly) Benchmarks
| Inogen Inc | -0.014M |
| Petros Pharmaceuticals Inc | -2.373M |
| DIH Holding US Inc | -- |
| NovaBay Pharmaceuticals Inc | -0.026M |
| Palatin Technologies Inc | 4.974M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.418M |
| Cash from Investing (Quarterly) | 30.00M |
| Free Cash Flow | -10.55M |
| Free Cash Flow Per Share (Quarterly) | -0.0342 |
| Free Cash Flow Yield | -11.07% |